Optimization and Integration of Nanosilver on Polycaprolactone Nanofibrous Mesh for Bacterial Inhibition and Wound Healing in vitro and in vivo [Corrigendum]

This article refers to:

Optimization and integration of nanosilver on polycaprolactone nanofibrous mesh for bacterial inhibition and wound healing in vitro and in vivo

Liu M, Luo G, Wang Y, et al. Int J Nanomedicine. 2017;12:6827-6840.

The authors have advised due to an error that occurred inadvertently at the time of figure assembly, Figure 7B on page 6834 is incorrect. The authors have also advised the magnification in the note section is incorrect.

The correct Figure 7 and caption are as follows.

Figure 7 Fluorescence microscopy photographes of GFP transgenic fibroblasts on the (A) PCL/DA, (B) PCL/NS0.5, (C) PCL/NS1.0 and (D) PCL/NS2.0 films. (E) The cell viability measured using CCK8 assay at day 1, 3 and 5 post-seeding.

Notes: Magnification ×100. *p<0.05.

Abbreviations: CCK8, Cell Counting Kit-8; DA, dopamine; GFP, green fluorescent protein; NS, nanosilver; PCL, polycaprolactone.

The authors apologize for these errors.